INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 175 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,008,000 | -20.3% | 10,000 | 0.0% | 0.12% | -28.2% |
| Q3 2018 | $1,264,000 | +50.7% | 10,000 | 0.0% | 0.17% | +24.1% |
| Q2 2018 | $839,000 | +290.2% | 10,000 | +185.7% | 0.14% | +204.4% |
| Q1 2018 | $215,000 | +5.4% | 3,500 | 0.0% | 0.04% | -61.9% |
| Q4 2017 | $204,000 | -77.3% | 3,500 | -50.0% | 0.12% | -77.9% |
| Q1 2016 | $899,000 | -14.0% | 7,000 | 0.0% | 0.53% | -2.2% |
| Q4 2015 | $1,045,000 | -10.0% | 7,000 | 0.0% | 0.55% | -3.2% |
| Q3 2015 | $1,161,000 | -31.3% | 7,000 | 0.0% | 0.56% | -35.8% |
| Q2 2015 | $1,690,000 | -14.4% | 7,000 | 0.0% | 0.88% | -16.1% |
| Q1 2015 | $1,974,000 | -9.6% | 7,000 | -50.0% | 1.05% | +65.6% |
| Q4 2014 | $2,184,000 | – | 14,000 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
| CM Management, LLC | 45,000 | $668,000 | 0.50% |
| EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
| DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
| Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
| Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
| Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
| DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |